AbCellera (Nasdaq: ABCL) today announced that the Company will participate in the following investor conferences:
- Wells Fargo Healthcare Conference, September 3-5, 2025
- Morgan Stanley Annual Global Healthcare Conference, September 8-10, 2025
Visit AbCellera's Investor Relations website for additional information.
About AbCellera Biologics Inc.
AbCellera (Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines in the areas of endocrinology, women's health, immunology, and oncology. For more information, please visit www.abcellera.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250812333835/en/
Contacts
Inquiries
Media: Tiffany Chiu; media@abcellera.com, +1(236)521-6774
Partnering: Murray McCutcheon, Ph.D.; partnering@abcellera.com, +1(604)559-9005
Investor Relations: Peter Ahn; ir@abcellera.com, +1(778)729-9116
If you believe this article contains misleading, harmful, or spam content, please let us know.
Report this article